New data has shown the best potential in Casdatives, an HIF-2A inhibitor, in patients with the metastatic kidney cancer
New data has shown the best potential in Casdatives, an HIF-2A inhibitor, in patients with the metastatic kidney cancer
Confirmed
0
Death
0
Sign in to your account